RT Journal Article
SR Electronic
T1 An outbreak of SARS-CoV-2 in a public-facing office in England, 2021
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2022.01.31.22269194
DO 10.1101/2022.01.31.22269194
A1 Atkinson, Barry
A1 van Veldhoven, Karin
A1 Nicholls, Ian
A1 Coldwell, Matthew
A1 Clarke, Adam
A1 Frost, Gillian
A1 Atchison, Christina J.
A1 Raja, Amber I.
A1 Bennett, Allan M
A1 Morgan, Derek
A1 Pearce, Neil
A1 Fletcher, Tony
A1 Brickley, Elizabeth B
A1 Chen, Yiqun
YR 2022
UL http://medrxiv.org/content/early/2022/02/01/2022.01.31.22269194.abstract
AB Between August-September 2021, an outbreak of SARS-CoV-2, with an attack rate of 55% (22/40 workers), occurred in a public-facing office in England. To identify workplace and worker-related risk factors, a comprehensive investigation involving surface sampling, environmental assessment, molecular and serological testing, and worker questionnaires was performed in September – October 2021. The results affirm the utility of surface sampling to identify SARS-CoV-2 control deficiencies and the importance of evolving, site-specific risk assessments with layered COVID-19 mitigation strategies.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was supported by funding from the PROTECT COVID-19 National Core Study on Transmission and Environment, managed by the Health and Safety Executive on behalf of HM Government.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:NHS North East Research Ethics Committee of the NHS gave ethical approval for this work (20/NE/0282)I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data produced in the present study are available upon reasonable request to the authors